Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cue Biopharma Inc V.CUE


Primary Symbol: CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.


NDAQ:CUE - Post by User

Post by marginedouton Oct 08, 2010 12:40pm
661 Views
Post# 17545743

Icke and Scuba 2223

Icke and Scuba 2223Icke is going after Stockhouse to identify Scuba2223. Good luck Scoobie but get a little legal advice.
ICKE, you act like a snivelling baby, your time would be better spent trying to do something about Cue's properties and prospects and the pitiful share price rather than spending the company's time and money to chase down one of your many detractors. You may or may not be a crook, I have no knowledge about that. But you would be hard pressed to say that you have had any great success in the mining world.
He should have pointed out  the share price and accomplishments of the companies of which you are or were  a director. Many have been delisted.  Most struggle to stay above a dime. You aspire for mediocrity. The lawsuit is an indication of just how insecure you are.  Grow up, do something useful!
<< Previous
Bullboard Posts
Next >>